278 related articles for article (PubMed ID: 1654808)
41. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
Ogata Y; Enghild JJ; Nagase H
J Biol Chem; 1992 Feb; 267(6):3581-4. PubMed ID: 1371271
[TBL] [Abstract][Full Text] [Related]
42. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
43. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
44. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
Xia T; Akers K; Eisen AZ; Seltzer JL
Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
[TBL] [Abstract][Full Text] [Related]
45. Identification, partial purification and characterization of high-molecular-weight gelatin-degrading metalloproteinases produced by a rat mammary carcinoma cell line.
Nethery A; O'Grady RL
Biochim Biophys Acta; 1989 Oct; 993(1):42-7. PubMed ID: 2553121
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of purified collagenase from alkali-burned rabbit corneas.
Burns FR; Stack MS; Gray RD; Paterson CA
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1569-75. PubMed ID: 2545645
[TBL] [Abstract][Full Text] [Related]
47. Purification and substrate specificity of a strongly hydrophobic extracellular metalloendopeptidase ("gelatinase") from Streptococcus faecalis (strain 0G1-10).
Mäkinen PL; Clewell DB; An F; Mäkinen KK
J Biol Chem; 1989 Feb; 264(6):3325-34. PubMed ID: 2536744
[TBL] [Abstract][Full Text] [Related]
48. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA
J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973
[TBL] [Abstract][Full Text] [Related]
50. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
[TBL] [Abstract][Full Text] [Related]
51. Purification of pig synovial collagenase to high specific activity.
Cawston TE; Tyler JA
Biochem J; 1979 Dec; 183(3):647-56. PubMed ID: 231970
[TBL] [Abstract][Full Text] [Related]
52. Purification and characterization of a new tissue inhibitor of metalloproteinases (TIMP-2) from mouse colon 26 tumor cells.
Kishi J; Ogawa K; Yamamoto S; Hayakawa T
Matrix; 1991 Feb; 11(1):10-6. PubMed ID: 1851244
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).
Suzuki K; Enghild JJ; Morodomi T; Salvesen G; Nagase H
Biochemistry; 1990 Nov; 29(44):10261-70. PubMed ID: 2176865
[TBL] [Abstract][Full Text] [Related]
54. Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro.
Tetlow LC; Harper N; Dunningham T; Morris MA; Bertfield H; Woolley DE
Ann Rheum Dis; 1998 Jan; 57(1):25-32. PubMed ID: 9536819
[TBL] [Abstract][Full Text] [Related]
55. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.
Howard EW; Bullen EC; Banda MJ
J Biol Chem; 1991 Jul; 266(20):13070-5. PubMed ID: 1649175
[TBL] [Abstract][Full Text] [Related]
56. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.
Moutsiakis D; Mancuso P; Krutzsch H; Stetler-Stevenson W; Zucker S
Connect Tissue Res; 1992; 28(3):213-30. PubMed ID: 1468208
[TBL] [Abstract][Full Text] [Related]
57. Purification, characterization and inhibition of human skin collagenase.
Woolley DE; Glanville RW; Roberts DR; Evanson JM
Biochem J; 1978 Feb; 169(2):265-76. PubMed ID: 204294
[TBL] [Abstract][Full Text] [Related]
58. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
Lefebvre V; Peeters-Joris C; Vaes G
Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
[TBL] [Abstract][Full Text] [Related]
59. Natural human monocyte gelatinase and its inhibitor.
Opdenakker G; Masure S; Proost P; Billiau A; van Damme J
FEBS Lett; 1991 Jun; 284(1):73-8. PubMed ID: 1647974
[TBL] [Abstract][Full Text] [Related]
60. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
